Others surely felt that DSL and its technology were a waste, but I never did, nor have I ever heard acogentargument that suggests this area will not remain a dominant form of broadband for decades to come.
Yet, without acogent economic argument for payors (and, increasingly, for regulators), drug developers are going to have an increasingly difficult time getting their products into the hands of their primary customers.